Detalhe da pesquisa
1.
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Blood
; 141(24): 2932-2943, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862975
2.
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.
Blood
; 139(19): 2983-2997, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226736
3.
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.
Blood
; 137(3): 420-428, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475736
4.
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood
; 138(3): 273-282, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292325
5.
The clinical and functional effects of TERT variants in myelodysplastic syndrome.
Blood
; 138(10): 898-911, 2021 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019641
6.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Blood
; 137(23): 3212-3217, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720354
7.
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
Blood
; 136(26): 3070-3081, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367544
8.
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Blood
; 135(2): 97-107, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738834
9.
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.
Blood
; 135(1): 28-40, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697815
10.
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Haematologica
; 107(11): 2617-2629, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484649
11.
SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.
Hum Mutat
; 42(11): 1367-1383, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298585
12.
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease.
Blood
; 133(1): 94-99, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279226
13.
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.
Biol Blood Marrow Transplant
; 26(5): e94-e100, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035274
14.
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.
Biol Blood Marrow Transplant
; 26(4): 798-804, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756536
15.
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(3): 529-539, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678537
16.
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(3): 606-611, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31715306
17.
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
N Engl J Med
; 376(6): 536-547, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28177873
18.
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Blood
; 131(25): 2836-2845, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29549175
19.
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Blood
; 131(12): 1372-1379, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437593
20.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Blood
; 141(15): 1884-1888, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332187